Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.
Huaquan WangHaiyue NiuTian ZhangLimin XingZonghong ShaoRong FuPublished in: Hematology (Amsterdam, Netherlands) (2021)
Low- and intermediate-risk MDS with PRCA was difficult to treat, but the prognosis was good.
Keyphrases